Antiviral Therapies in Pediatric Influenza: What Does the Current Data Say?

Program Overview

In order to possess a working knowledge of the latest therapeutic advances and treatment strategies, clinicians need to stay up-to-date on the latest clinical data. This activity will consist of a 15-minute video-based presentation by one nationally recognized expert in the treatment of pediatric influenza focused on the latest clinical data and critical analysis of late-breaking clinical trial data in order to help clinicians stay current and provide optimal care for patients.

Credit Expired

Target Audience

Pediatricians, family practice, and primary care clinicians managing pediatric patients with influenza.

Educational Objectives

Upon completion of this activity, participants should be better able to:

Differentiate between antiviral therapies for influenza prevention and treatment in young children according to their efficacy and safety

Personalize antiviral therapy for influenza prevention and treatment in pediatric patients

Activity Faculty

Charles P. Vega, MD, FAAFP

Assistant Dean, Culture and Community Education
School of Medicine
University of California – Irvine
Irvine, CA

Considering Therapies for Influenza Treatment and Post-Exposure in Children

Featured RMEI CE Activities – Earn CE Credit(s)

Antiviral Therapies in Pediatric Influenza: What Does the Current Data Say?

Program Overview

Target Audience

Educational Objectives

Activity Faculty

Charles P. Vega, MD, FAAFP

Considering Therapies for Influenza Treatment and Post-Exposure in Children

Advances in Precision Medicine for Relapsed/Refractory Diffuse Large B-Cell Lymphoma Care: A Care Team Forum®

Refining Management of CMV After Transplant: Exploiting Recent Advances to Alleviate Patient Burden

Overcoming Obstacles to Optimal Multiple Sclerosis (MS) Care in Minority Patient Populations

Subscribe